Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2003
11/27/2003CA2483770A1 Trimegestone and estrogens for treating post menopausal disorders
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/27/2003CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/26/2003EP1365024A1 Traf3-binding b cell-specific receptor
11/26/2003EP1364953A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364949A1 Jnk inhibitor
11/26/2003EP1364943A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364002A2 Process for the preparation of neutrophil inhibitory factor
11/26/2003EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK)
11/26/2003EP1363950A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors
11/26/2003EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof
11/26/2003EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
11/26/2003EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof
11/26/2003EP1363904A1 Pyrazoles as tgf inhibitors
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363900A1 Isoindole-imide compounds as tnf-inhibitors
11/26/2003EP1363899A1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363897A2 Antagonists of mcp-1 function and methods of use thereof
11/26/2003EP1363895A2 Process for the production of tocotrienols
11/26/2003EP1363891A2 Anthrone derivatives and their use as jnk inhibitors
11/26/2003EP1363885A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
11/26/2003EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity
11/26/2003EP1363874A2 Tryptase inhibitors
11/26/2003EP1363702A1 Methods of inhibiting kinases
11/26/2003EP1363677A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing
11/26/2003EP1363659A2 Method of treating rhinitis or sinusitis
11/26/2003EP1363658A2 Local pain-combating agent
11/26/2003EP1363651A1 Herbal compositions useful as chemopreventive and therapeutic agents
11/26/2003EP1363648A1 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363629A1 Kappa opioid receptor ligands
11/26/2003EP1363619A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
11/26/2003EP1363613A2 Use of rhein for preparing a medicine for treating a high rate of il-1
11/26/2003EP1363608A1 Treatment of sleep disturbances
11/26/2003EP1363605A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
11/26/2003EP1363604A2 Pharmaceutical formulation
11/26/2003EP1363602A1 Local anesthetic, and method of use
11/26/2003EP1363594A1 Cosmetic formulations containing flavonoid derivatives
11/26/2003EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs
11/26/2003EP1363508A1 Emulsions and aqueous dispersions of phytosterols
11/26/2003EP1268487B1 Tricyclic protein kinase inhibitors
11/26/2003EP1083902B1 Novel galenic formulations of meloxicam for oral administration
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP1025096B1 Substituted chroman derivatives
11/26/2003EP1025095B1 Substituted chroman derivatives
11/26/2003EP0923546B1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
11/26/2003EP0814813B1 Use of penciclovir for the treatment of human herpes-virus-8
11/26/2003EP0765326B1 Benzoylecgonine, ecgonine and ecgonidine derivatives
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/26/2003CN1458926A Nitric oxide donors based on metallic centres
11/26/2003CN1458922A Urea derivative and adhesive-molecule inhibitor containing same as ctive ingredient
11/26/2003CN1458846A Synthetic erythropoiesis stimulating protein
11/26/2003CN1458844A Method of using diketopiperazines and composition containing them
11/26/2003CN1457878A Powder for treating chronic inflammation
11/26/2003CN1457864A Pill for treating pestilence, high fever and headache
11/26/2003CN1457859A Chinese patent medicine for treating rheumatism and its prepn
11/26/2003CN1457855A Yin-toxin source eliminating pill
11/26/2003CN1457852A Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method
11/26/2003CN1457851A Chinese medicine formula with treating and health function
11/26/2003CN1457845A Medicinal wine for curing old injury recurrent pain
11/26/2003CN1457834A Detoxicating pill
11/26/2003CN1457820A Pill for eliminating stagnation and pains
11/26/2003CN1457815A Capsule for relaxing muscles and tendons and activating flow of qi and blood channels and collaterals, and expelling wind
11/26/2003CN1457813A Medicine for curing rheumatism and traumatic injury
11/26/2003CN1128800C Pyrolo [2,3-d] pyrimidine compounds and its composition and use
11/26/2003CN1128635C Amber anti-inflammatory pain-stopping powder medicine
11/26/2003CN1128627C Plaster for treating rheumatism and its preparing method
11/26/2003CN1128614C Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and preparation containing it
11/26/2003CN1128612C Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653476 Thienopyridine derivatives, their production and use
11/25/2003US6653448 Wnt-7B-like polypeptides and nucleic acids encoding same
11/25/2003US6653348 Antiinflammatory agent for humans
11/25/2003US6653347 For therapy
11/25/2003US6653334 Benzoxazole compound and pharmaceutical composition containing the same
11/25/2003US6653322 Therapeutic combinations of RAR antagonists and RXR agonists and use thereof
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653308 Anticancer agents; antidiabetic agents; antiinflammatory agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653133 Antisense modulation of Fas mediated signaling
11/25/2003US6653131 Method of treating systemic inflammatory response syndrome
11/25/2003US6653116 Peptide for use in the treatment of inflammation, cancer, arteriosclerosis and psoriasis
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/25/2003US6652856 Method for the treatment of fibrosis
11/25/2003US6652855 Treatment of LFA-1 associated disorders with increasing doses of LFA-1 antagonist
11/25/2003CA2266666C Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
11/25/2003CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions